Great investor presentation:
I like the peer comparison on page 20 but also take notice of the following statement(s);
Lets see how this unfolds..
- There are currently only four approved drugs to treat Alzheimer’s, none of which modify the underlying disease and only provide limited benefit for around six months.
- Sales of the leading global treatment, Aricept totaled $2.5bn in 2016 (even as a generic medicine), showing that XanamemTM has the potential to be a blockbuster treatment.
DYOR
Ann: Latest Investor Presentation, page-2
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
